Andrea Apolo is a nationally and internationally recognized expert in bladder cancer research. Her research involves developing and designing clinical trials to test novel therapies for bladder, kidney, and rare genitourinary cancers.
Darren Feldman leads national and international clinical trials for people with genitourinary cancers. He specialize in treating germ cell and kidney cancers. His research centers on developing new drugs or drug combinations for people with these cancers.
Alex Wyatt's primary research goals are to identify associations between molecular alterations in metastatic genitourinary cancers and clinical outcomes, and to translate these findings into clinical biomarkers.
Sima Porten's research interests focus mainly in the diagnosis and management of urothelial carcinoma. She hopes to develop new tests and novel therapeutics to bring personalized medicine to patients with bladder cancer.